Hot Stocks: Brokerage view on IndiGo, L&T, Epigral and Anant Raj

Goldman Sachs on IndiGo: Buy| Target: Rs 4,700

Goldman Sachs maintained a buy rating on InterGlobe Aviation-held IndiGo as the near-term cost pressures. but the long-term story remains intact. If fresh deliveries of aircraft lag, then it will put pressure on costs, however, market share gains to continue.

One can expect international travel to grow at a CAGR of 13% till 2030.

UBS on L&T: Buy| Target: 4,180

UBS maintained a buy rating on L&T stating that the near-term catalysts are limited, but so are expectations. They believe order intake growth has peaked and L&T will now focus on execution and managing project-level risks. The company’s margins and execution are looking better for FY25/26, while new orders growth and net working capital are likely to be lower vs FY23/24.

Emkay on Epigral: Buy| Target: Rs 2,000

Emkay Global initiated coverage on Epigral with a target price of Rs 2,000 stating that the company is a valorization to valuation story. The caustic soda cycle is bottoming out and chlorine derivatives contribution is likely to increase. ECH and CPVC are low hanging fruits while chlorotoluene will ramp up by FY26. Earnings to consistently clock 25%+ CAGR, with healthy return ratios.

DAM Capital on Anant Raj: Buy| Target: Rs 620

DAM Capital initiated coverage on Anant Raj with a target price of Rs 620 saying that a strong pipeline exists in a well-placed realty market. Time and cost advantage in high-yielding data center space and there is a sharp improvement in financial parameters. The brokerage firm expects revenue/EBITDA to rise at a CAGR of 35%/65% from FY24 to FY26.

Further, EBITDA margin is likely to improve from 23% in FY24 to 34% in FY26 driven by high-margin data center business and launch of luxury residential projects. DAM Capital believes that the data center potential is not yet priced in, however, the street is waiting for further execution of capacity expansion.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)